205 related articles for article (PubMed ID: 27621597)
1. Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma.
Kuna P; Bjermer L; Tornling G
Drug Des Devel Ther; 2016; 10():2759-70. PubMed ID: 27621597
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β
Bateman ED; O'Brien C; Rugman P; Luke S; Ivanov S; Uddin M
Drug Des Devel Ther; 2018; 12():1093-1106. PubMed ID: 29765200
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of AZD1981, a CRTH2 receptor antagonist, in patients with moderate to severe COPD.
Snell N; Foster M; Vestbo J
Respir Med; 2013 Nov; 107(11):1722-30. PubMed ID: 23827726
[TBL] [Abstract][Full Text] [Related]
4. Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.
Oliver ET; Chichester K; Devine K; Sterba PM; Wegner C; Vonakis BM; Saini SS
Int Arch Allergy Immunol; 2019; 179(1):21-30. PubMed ID: 30879003
[TBL] [Abstract][Full Text] [Related]
5. The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma.
Erpenbeck VJ; Popov TA; Miller D; Weinstein SF; Spector S; Magnusson B; Osuntokun W; Goldsmith P; Weiss M; Beier J
Pulm Pharmacol Ther; 2016 Aug; 39():54-63. PubMed ID: 27354118
[TBL] [Abstract][Full Text] [Related]
6. Heightened response of eosinophilic asthmatic patients to the CRTH2 antagonist OC000459.
Pettipher R; Hunter MG; Perkins CM; Collins LP; Lewis T; Baillet M; Steiner J; Bell J; Payton MA
Allergy; 2014 Sep; 69(9):1223-32. PubMed ID: 24866478
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.
Hall IP; Fowler AV; Gupta A; Tetzlaff K; Nivens MC; Sarno M; Finnigan HA; Bateman ED; Rand Sutherland E
Pulm Pharmacol Ther; 2015 Jun; 32():37-44. PubMed ID: 25861737
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma.
Miller D; Wood C; Bateman E; LaForce C; Blatchford J; Hilbert J; Gupta A; Fowler A
Allergy Asthma Proc; 2017 Mar; 38(2):157-164. PubMed ID: 28234053
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma.
Barnes N; Pavord I; Chuchalin A; Bell J; Hunter M; Lewis T; Parker D; Payton M; Collins LP; Pettipher R; Steiner J; Perkins CM
Clin Exp Allergy; 2012 Jan; 42(1):38-48. PubMed ID: 21762224
[TBL] [Abstract][Full Text] [Related]
11. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
[TBL] [Abstract][Full Text] [Related]
12. Setipiprant, a selective CRTH2 antagonist, reduces allergen-induced airway responses in allergic asthmatics.
Diamant Z; Sidharta PN; Singh D; O'Connor BJ; Zuiker R; Leaker BR; Silkey M; Dingemanse J
Clin Exp Allergy; 2014 Aug; 44(8):1044-52. PubMed ID: 24964348
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients.
Busse WW; Wenzel SE; Meltzer EO; Kerwin EM; Liu MC; Zhang N; Chon Y; Budelsky AL; Lin J; Lin SL
J Allergy Clin Immunol; 2013 Feb; 131(2):339-45. PubMed ID: 23174659
[TBL] [Abstract][Full Text] [Related]
14. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma.
Fowler A; Koenen R; Hilbert J; Blatchford J; Kappeler D; Benediktus E; Wood C; Gupta A
J Clin Pharmacol; 2017 Nov; 57(11):1444-1453. PubMed ID: 28609567
[TBL] [Abstract][Full Text] [Related]
15. Exploring the insulin secretory properties of the PGD2-GPR44/DP2 axis in vitro and in a randomized phase-1 trial of type 2 diabetes patients.
Skrtic S; Tyrberg B; Broberg M; Ericsson H; Schnecke V; Kjaer M; Hompesch M; Andersson EM; Ryberg E; Aivazidis A; Wennberg Huldt C; Löfgren L; Morrow L; Parkinson J; Rydén-Bergsten T; Watkins E; Sörhede Winzell M
PLoS One; 2018; 13(12):e0208998. PubMed ID: 30557325
[TBL] [Abstract][Full Text] [Related]
16. Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981.
Luker T; Bonnert R; Brough S; Cook AR; Dickinson MR; Dougall I; Logan C; Mohammed RT; Paine S; Sanganee HJ; Sargent C; Schmidt JA; Teague S; Thom S
Bioorg Med Chem Lett; 2011 Nov; 21(21):6288-92. PubMed ID: 21944852
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of antagonists for chemoattractant receptor-homologous molecule expressed on Th2 cells in adult patients with asthma: a meta-analysis and systematic review.
Yang J; Luo J; Yang L; Yang D; Wang D; Liu B; Huang T; Wang X; Liang B; Liu C
Respir Res; 2018 Nov; 19(1):217. PubMed ID: 30413187
[TBL] [Abstract][Full Text] [Related]
18. Montelukast: a review of its therapeutic potential in persistent asthma.
Jarvis B; Markham A
Drugs; 2000 Apr; 59(4):891-928. PubMed ID: 10804041
[TBL] [Abstract][Full Text] [Related]
19. Fevipiprant, an oral prostaglandin DP
Bateman ED; Guerreros AG; Brockhaus F; Holzhauer B; Pethe A; Kay RA; Townley RG
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28838980
[TBL] [Abstract][Full Text] [Related]
20. Single- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects.
Sidharta PN; Diamant Z; Dingemanse J
Fundam Clin Pharmacol; 2014 Dec; 28(6):690-9. PubMed ID: 24734908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
